Site-specific hyperphosphorylation of pRb in HIV-induced neurotoxicity

Molecular and Cellular Neuroscience

Volumn 47, Issue 2, 2011, Pages 154-165

  Akay, C ^a   Lindl, K A ^a   Wang, Y ^a   White, M G ^a   Isaacman Beck, J ^a   Kolson, D L ^a   Jordan Sciutto, K L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Chemokines; Cyclin dependent kinase; Cyclin dependent kinase 5; HIV Associated Neurocognitive Disorder; Neurotrophins; Retinoblastoma

Indexed keywords

ANTIRETROVIRUS AGENT; CHEMOKINE; CYCLIN DEPENDENT KINASE 5; ISOPROTEIN; NEUROTROPHIN; RETINOBLASTOMA PROTEIN; SERINE; THREONINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CYCLE; CELL DEATH; CONTROLLED STUDY; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IN VITRO STUDY; MACROPHAGE ACTIVATION; MITOSIS; NERVE DEGENERATION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; VIRUS ENCEPHALITIS;

ADULT; AIDS DEMENTIA COMPLEX; ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL DEATH; CELLS, CULTURED; CHEMOKINE CCL5; CYCLIN-DEPENDENT KINASE 5; HIV INFECTIONS; HIV-1; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MACROPHAGES; MALE; MIDDLE AGED; NEUROGLIA; NEURONS; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; RETINOBLASTOMA PROTEIN; SERINE;

RATTUS;

EID: 79955961268     PISSN: 10447431     EISSN: 10959327     Source Type: Journal    
DOI: 10.1016/j.mcn.2011.04.001     Document Type: Article

References (81)

1. Achim C.L., Masliah E., Heyes M.P., Sarnacki P., Hilty C., Baldwin M., Wiley C.A. Macrophage activation factorsin the brains of AIDS patients. J. NeuroAIDS 1996, 1:1-16.
2. Barnabe-Heider F., Miller F.D. Endogenously produced neurotrophins regulate survival and differentiation of cortical progenitors via distinct signaling pathways. J. Neurosci. 2003, 23:5149-5160.
3. Benoit B.O., Savarese T., Joly M., Engstrom C.M., Pang L., Reilly J., Recht L.D., Ross A.H., Quesenberry P.J. Neurotrophin channeling of neural progenitor cell differentiation. J. Neurobiol. 2001, 46:265-280.
4. Brewer G.J. Serum-free B27/neurobasal medium supports differentiated growth of neurons from the striatum, substantia nigra, septum, cerebral cortex, cerebellum, and dentate gyrus. J. Neurosci. Res. 1995, 42:674-683.
5. Burke J.R., Deshong A.J., Pelton J.G., Rubin S.M. Phosphorylation-induced conformational changes in the retinoblastoma protein inhibit E2F transactivation domain binding. J. Biol. Chem. 2010, 285:16286-16293.
6. Chen W., Sulcove J., Frank I., Jaffer S., Ozdener H., Kolson D.L. Development of a human neuronal cell model for human immunodeficiency virus (HIV)-infected macrophage-induced neurotoxicity: apoptosis induced by HIV type 1 primary isolates and evidence for involvement of the Bcl-2/Bcl-xL-sensitive intrinsic apoptosis pathway. J. Virol. 2002, 76:9407-9419.
7. Chergui K., Svenningsson P., Greengard P. Cyclin-dependent kinase 5 regulates dopaminergic and glutamatergic transmission in the striatum. Proc. Natl Acad. Sci. U. S. A. 2004, 101:2191-2196.
8. Cheung Z.H., Chin W.H., Chen Y., Ng Y.P., Ip N.Y. Cdk5 is involved in BDNF-stimulated dendritic growth in hippocampal neurons. PLoS Biol. 2007, 5:e63.
9. Conant K., Garzino-Demo A., Nath A., McArthur J.C., Halliday W., Power C., Gallo R.C., Major E.O. Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. Proc. Natl Acad. Sci. U. S. A. 1998, 95:3117-3121.
10. Connell-Crowley L., Harper J.W., Goodrich D.W. Cyclin D1/Cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation. Mol. Biol. Cell 1997, 8:287-301.
11. DeGregori J., Leone G., Miron A., Jakoi L., Nevins J. Distinct roles for E2F proteins in cell growth control and apoptosis. Proc. Natl Acad. Sci. U. S. A. 1997, 94:7245-7250.
12. Dhavan R., Tsai L.H. A decade of CDK5. Nat. Rev. Mol. Cell Biol. 2001, 2:749-759.
13. Dore G.J., Correll P.K., Li Y., Kaldor J.M., Cooper D.A., Brew B.J. Changes to AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS (London, England) 1999, 13:1249-1253.
14. Everall I.P., Trillo-Pazos G., Bell C., Mallory M., Sanders V., Masliah E. Amelioration of neurotoxic effects of HIV envelope protein gp120 by fibroblast growth factor: a strategy for neuroprotection. J. Neuropathol. Exp. Neurol. 2001, 60:293-301.
15. Freeman R., Estus S., Johnson E. Analysis of cell cycle-related gene expression in postmitotic neurons: selective induction of cyclin D1 during programmed cell death. Neuron 1994, 12:343-355.
16. Frolov M.V., Dyson N.J. Molecular mechanisms of E2F-dependent activation and pRB-mediated repression. J. Cell Sci. 2004, 117:2173-2181.
17. Fukumitsu H., Ohtsuka M., Murai R., Nakamura H., Itoh K., Furukawa S. Brain-derived neurotrophic factor participates in determination of neuronal laminar fate in the developing mouse cerebral cortex. J. Neurosci. 2006, 26:13218-13230.
18. Galicia O., Sanchez-Alavez M., Mendez Diaz M., Navarro L., Prospero-Garcia O. HIV glycoprotein 120: possible etiological agent of AIDS-associated dementia. Rev. Invest. Clin. 2002, 54:437-452.
19. Gendelman H.E., Lipton S.A., Tardieu M., Bukrinsky M.I., Nottet H.S. The Neuropathogenesis of HIV-1 Infection 1994, [see comment]. [Review] [107 refs].
20. Giovanni A., Wirtz-Bruger F., Keramaris E., Slack R., Park D. Involvement of cell cycle elements, cyclin-dependent kinases, pRb, and E2F-DP, in B-amyloid-induced neuronal death. J. Biol. Chem. 1999, 274:19011-19016.
21. Gisolf E.H., van Praag R.M., Jurriaans S., Portegies P., Goudsmit J., Danner S.A., Lange J.M., Prins J.M. Increasing cerebrospinal fluid chemokine concentrations despite undetectable cerebrospinal fluid HIV RNA in HIV-1-infected patients receiving antiretroviral therapy. J. Acquir. Immune Defic. Syndr. 2000, 25:426-433.
22. Giulian D., Yu J., Li X., Tom D., Li J., Wendt E., Lin S.N., Schwarcz R., Noonan C. Study of receptor-mediated neurotoxins released by HIV-1-infected mononuclear phagocytes found in human brain. J. Neurosci. 1996, 16:3139-3153.
23. Gonzalez-Scarano F., Martin-Garcia J. The neuropathogenesis of AIDS. Nat. Rev. 2005, 5:69-81.
24. Gonzalez-Scarano F., Martin-Garcia J. The Neuropathogenesis of AIDS 2005, [Review] [173 refs].
25. Hallstrom T.C., Nevins J.R. Specificity in the activation and control of transcription factor E2F-dependent apoptosis. Proc. Natl Acad. Sci. U. S. A. 2003, 100:10848-10853.
26. Hamdane M., Bretteville A., Sambo A.V., Schindowski K., Begard S., Delacourte A., Bertrand P., Buee L. p25/Cdk5-mediated retinoblastoma phosphorylation is an early event in neuronal cell death. J. Cell Sci. 2005, 118:1291-1298.
27. Hamel P.A., Cohen B.L., Sorce L.M., Gallie B.L., Phillips R.A. Hyperphosphorylation of the retinoblastoma gene product is determined by domains outside the simian virus 40 large-T-antigen-binding regions. Mol. Cell. Biol. 1990, 10:6586-6595.
28. Harbott L.K., Nobes C.D. A key role for Abl family kinases in EphA receptor-mediated growth cone collapse. Mol. Cell. Neurosci. 2005, 30:1-11.
29. Harbour J.W., Dean D.C. Rb function in cell-cycle regulation and apoptosis. Nat. Cell Biol. 2000, 2:E65-E67.
30. Harbour J.W., Dean D.C. The Rb/E2F pathway: expanding roles and emerging paradigms. Genes Dev. 2000, 14:2393-2409.
31. Heaton R.K., Clifford D.B., Franklin D.R., Woods S.P., Ake C., Vaida F., Ellis R.J., Letendre S.L., Marcotte T.D., Atkinson J.H., Rivera-Mindt M., Vigil O.R., Taylor M.J., Collier A.C., Marra C.M., Gelman B.B., McArthur J.C., Morgello S., Simpson D.M., McCutchan J.A., Abramson I., Gamst A., Fennema-Notestine C., Jernigan T.L., Wong J., Grant I. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology 2010, 75:2087-2096.
32. Henchcliffe C., Burke R.E. Increased expression of cyclin-dependent kinase 5 in induced apoptotic neuron death in rat substantia nigra. Neurosci. Lett. 1997, 230:41-44.
33. Inoue Y., Kitagawa M., Taya Y. Phosphorylation of pRB at Ser612 by Chk1/2 leads to a complex between pRB and E2F-1 after DNA damage. EMBO J. 2007, 26:2083-2093.
34. Jones S.B., Lu H.Y., Lu Q. Abl tyrosine kinase promotes dendrogenesis by inducing actin cytoskeletal rearrangements in cooperation with Rho family small GTPases in hippocampal neurons. J. Neurosci. 2004, 24:8510-8521.
35. Jordan-Sciutto K.L., Wang G., Murphy-Corb M., Wiley C.A. Induction of cell-cycle regulators in simian immunodeficiency virus encephalitis. Am. J. Pathol. 2000, 157:497-507.
36. Jordan-Sciutto K., Rhodes J., Bowser R. Altered subcellular distribution of transcriptional regulators in response to Abeta peptide and during Alzheimer's disease. Mech. Ageing Dev. 2001, 123:11-20.
37. Jordan-Sciutto K.L., Malaiyandi L.M., Bowser R. Altered distribution of cell cycle transcriptional regulators during Alzheimer disease. J. Neuropathol. Exp. Neurol. 2002, 61:358-367.
38. Jordan-Sciutto K.L., Wang G., Murphey-Corb M., Wiley C.A. Cell cycle proteins exhibit altered expression patterns in lentiviral-associated encephalitis. J. Neurosci. 2002, 22:2185-2195.
39. Jordan-Sciutto K.L., Dorsey R., Chalovich E.M., Hammond R.R., Achim C.L. Expression patterns of retinoblastoma protein in Parkinson disease. J. Neuropathol. Exp. Neurol. 2003, 62:68-74.
40. Kaul M., Zheng J., Okamoto S., Gendelman H.E., Lipton S.A. HIV-1 infection and AIDS: consequences for the central nervous system 2005, [Review] [199 refs].
41. Khan M.Z., Brandimarti R., Shimizu S., Nicolai J., Crowe E., Meucci O. The chemokine CXCL12 promotes survival of postmitotic neurons by regulating Rb protein. Cell Death Differ. 2008, 15:1663-1672.
42. Kitagawa M., Higashi H., Jung H.K., Suzuki-Takahashi I., Ikeda M., Tamai K., Kato J., Segawa K., Yoshida E., Nishimura S., Taya Y. The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2. EMBO J. 1996, 15:7060-7069.
43. Knudsen E.S., Wang J.Y. Differential regulation of retinoblastoma protein function by specific Cdk phosphorylation sites. J. Biol. Chem. 1996, 271:8313-8320.
44. Knudsen E.S., Wang J.Y. Dual mechanisms for the inhibition of E2F binding to RB by cyclin-dependent kinase-mediated RB phosphorylation. Mol. Cell. Biol. 1997, 17:5771-5783.
45. Kranenburg O., van der Eb A.J., Zantema A. Cyclin D1 is an essential mediator of apoptotic neuronal cell death. EMBO J. 1996, 15:46-54.
46. Lees J.A., Buchkovich K.J., Marshak D.R., Anderson C.W., Harlow E. The retinoblastoma protein is phosphorylated on multiple sites by human cdc2. EMBO J. 1991, 10:4279-4290.
47. Lin B.T., Gruenwald S., Morla A.O., Lee W.H., Wang J.Y. Retinoblastoma cancer suppressor gene product is a substrate of the cell cycle regulator cdc2 kinase. EMBO J. 1991, 10:857-864.
48. Lindl K.A., Akay C., Wang Y., White M.G., Jordan-Sciutto K.L. Expression of the endoplasmic reticulum stress response marker, BiP, in the central nervous system of HIV-positive individuals. Neuropathol. Appl. Neurobiol. 2007, 33:658-669.
49. Liu D.X., Greene L.A. Neuronal apoptosis at the G1/S cell cycle checkpoint. Cell Tissue Res. 2001, 305:217-228.
50. Llano A., Barretina J., Gutierrez A., Clotet B., Este J.A. Interleukin-7-dependent production of RANTES that correlates with human immunodeficiency virus disease progression. J. Virol. 2003, 77:4389-4395.
51. Maness P.F. Nonreceptor protein tyrosine kinases associated with neuronal development. Dev. Neurosci. 1992, 14:257-270.
52. Masliah E., DeTeresa R.M., Mallory M.E., Hansen L.A. Changes in pathological findings at autopsy in AIDS cases for the last 15years. AIDS (London, England) 2000, 14:69-74.
53. McArthur J.C. HIV dementia: an evolving disease. J. Neuroimmunol. 2004, 157:3-10.
54. Navia B.A., Cho E.S., Petito C.K., Price R.W. The AIDS dementia complex: II. Neuropathology. Ann. Neurol. 1986, 19:525-535.
55. Neuenburg J.K., Brodt H.R., Herndier B.G., Bickel M., Bacchetti P., Price R.W., Grant R.M., Schlote W. HIV-related neuropathology, 1985 to 1999: rising prevalence of HIV encephalopathy in the era of highly active antiretroviral therapy. J. Acquir. Immune Defic. Syndr. 2002, 31:171-177.
56. Nguyen M.D., Lariviere R.C., Julien J.P. Deregulation of Cdk5 in a mouse model of ALS: toxicity alleviated by perikaryal neurofilament inclusions. Neuron 2001, 30:135-147.
57. Nuovo G.J., Alfieri M.L. AIDS dementia is associated with massive, activated HIV-1 infection and concomitant expression of several cytokines. Mol. Med. 1996, 2:358-366.
58. O'Donnell L.A., Agrawal A., Jordan-Sciutto K.L., Dichter M.A., Lynch D.R., Kolson D.L. Human immunodeficiency virus (HIV)-induced neurotoxicity: roles for the NMDA receptor subtypes. J. Neurosci. 2006, 26:981-990.
59. Padmanabhan J., Park D.S., Greene L.A., Shelanski M.L. Role of cell cycle regulatory proteins in cerebellar granule neuron apoptosis. J. Neurosci. 1999, 19:8747-8756.
60. Pei J.J., Grundke-Iqbal I., Iqbal K., Bogdanovic N., Winblad B., Cowburn R.F. Accumulation of cyclin-dependent kinase 5 (cdk5) in neurons with early stages of Alzheimer's disease neurofibrillary degeneration. Brain Res. 1998, 797:267-277.
61. Pei J.J., Grundke-Iqbal I., Iqbal K., Bogdanovic N., Winblad B., Cowburn R.F. Accumulation of cyclin-dependent kinase 5 (cdk5) in neurons with early stages of Alzheimer's disease neurofibrillary degeneration. Brain Res. 1998, 797:267-277.
62. Portegies P., Enting R.H., deGans J., Algra P.R., Derix M.M., Lange J.M., Goudsmit J. Presentation and course of AIDS dementia complex: 10 years of follow-up in Amsterdam, The Netherlands. AIDS (London, England) 1993, 7:669-675.
63. Power C., Johnson R.T. HIV-1 associated dementia: clinical features and pathogenesis. Can. J. Neurol. Sci. 1995, 22:92-100.
64. Price R.W., Brew B., Sidtis J., Rosenblum M., Scheck A.C., Cleary P. The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science 1988, 239:586-592.
65. Ranganathan S., Bowser R. Alterations in G(1) to S phase cell-cycle regulators during amyotrophic lateral sclerosis. Am. J. Pathol. 2003, 162:823-835.
66. Rubin S.M., Gall A.L., Zheng N., Pavletich N.P. Structure of the Rb C-terminal domain bound to E2F1-DP1: a mechanism for phosphorylation-induced E2F release. Cell 2005, 123:1093-1106.
67. Sippy B.D., Hofman F.M., Wallach D., Hinton D.R. Increased expression of tumor necrosis factor-alpha receptors in the brains of patients with AIDS. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 1995, 10:511-521.
68. Soontornniyomkij V., Wang G., Pittman C.A., Wiley C.A., Achim C.L. Expression of brain-derived neurotrophic factor protein in activated microglia of human immunodeficiency virus type 1 encephalitis. Neuropathol. Appl. Neurobiol. 1998, 24:453-460.
69. Strachan G.D., Kopp A.S., Koike M.A., Morgan K.L., Jordan-Sciutto K.L. Chemokine- and neurotrophic factor-induced changes in E2F1 localization and phosphorylation of the retinoblastoma susceptibility gene product (pRb) occur by distinct mechanisms in murine cortical cultures 2005.
70. Takahashi J., Palmer T.D., Gage F.H. Retinoic acid and neurotrophins collaborate to regulate neurogenesis in adult-derived neural stem cell cultures. J. Neurobiol. 1999, 38:65-81.
71. Tseng H.C., Zhou Y., Shen Y., Tsai L.H. A survey of Cdk5 activator p35 and p25 levels in Alzheimer's disease brains. FEBS Lett. 2002, 523:58-62.
72. Ullrich C.K., Groopman J.E., Ganju R.K. HIV-1 gp120- and gp160-induced apoptosis in cultured endothelial cells is mediated by caspases. Blood 2000, 96:1438-1442.
73. Wang Y., White M.G., Akay C., Chodroff R.A., Robinson J., Lindl K.A., Dichter M.A., Qian Y., Mao Z., Kolson D.L., Jordan-Sciutto K.L. Activation of cyclin-dependent kinase 5 by calpains contributes to human immunodeficiency virus-induced neurotoxicity. J. Neurochem. 2007, 103:439-455.
74. Wang Y., Shyam N., Ting J.H., Akay C., Lindl K.A., Jordan-Sciutto K.L. E2F1 localizes predominantly to neuronal cytoplasm and fails to induce expression of its transcriptional targets in human immunodeficiency virus-induced neuronal damage. Neurosci. Lett. 2010, 479:97-101.
75. White M.G., Wang Y., Akay C., Lindl K.A., Kolson D.L., Jordan-Sciutto K.L. Parallel high throughput neuronal toxicity assays demonstrate uncoupling between loss of mitochondrial membrane potential and neuronal damage in a model of HIV-induced neurodegeneration. Neurosci. Res. 2011, 2011 Feb 1. (Electronic publication ahead of print).
76. Woodring P.J., Litwack E.D., O'Leary D.D., Lucero G.R., Wang J.Y., Hunter T. Modulation of the F-actin cytoskeleton by c-Abl tyrosine kinase in cell spreading and neurite extension. J. Cell Biol. 2002, 156:879-892.
77. Woods S., Moore D., Weber E., Grant I. Cognitive neuropsychology of HIV-Associated Neurocognitive Disorders. Neuropsychol. Rev. 2009, 19:152-168.
78. Yano H., Cong F., Birge R.B., Goff S.P., Chao M.V. Association of the Abl tyrosine kinase with the Trk nerve growth factor receptor. J. Neurosci. Res. 2000, 59:356-364.
79. Zarkowska T., Mittnacht S. Differential phosphorylation of the retinoblastoma protein by G1/S cyclin-dependent kinases. J. Biol. Chem. 1997, 272:12738-12746.
80. Zheng Y.L., Kesavapany S., Gravell M., Hamilton R.S., Schubert M., Amin N., Albers W., Grant P., Pant H.C. A Cdk5 inhibitory peptide reduces tau hyperphosphorylation and apoptosis in neurons. EMBO J. 2005, 24:209-220.
81. Zukerberg L.R., Patrick G.N., Nikolic M., Humbert S., Wu C.L., Lanier L.M., Gertler F.B., Vidal M., Van Etten R.A., Tsai L.H. Cables links Cdk5 and c-Abl and facilitates Cdk5 tyrosine phosphorylation, kinase upregulation, and neurite outgrowth. Neuron 2000, 26:633-646.